Financhill
Sell
24

ABCL Quote, Financials, Valuation and Earnings

Last price:
$3.59
Seasonality move :
-28.89%
Day range:
$3.57 - $3.73
52-week range:
$1.89 - $6.52
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
30.17x
P/B ratio:
1.11x
Volume:
2.6M
Avg. volume:
3.7M
1-year change:
18.15%
Market cap:
$1.1B
Revenue:
$28.8M
EPS (TTM):
-$0.58

Earnings Data

Next earnings date for ABCL
Feb 26
2026
Most recent earnings per share
-$0.19
Missed by $0.03
(Nov 6/2025)
Consensus Estimate
-$0.16
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ABCL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $6.3M -- -- -$0.19 --
11/06/2025 Q3 $6.3M $9M -$0.19 -$0.16 -$0.03
08/07/2025 Q2 $6.4M $17.1M -$0.12 -$0.16 $0.05
05/08/2025 Q1 $7.3M $4.2M -$0.15 -$0.14 -$0.01
02/27/2025 Q4 $7.6M $5.1M -$0.12 -$0.15 $0.04
11/04/2024 Q3 $8M $6.5M -$0.17 -$0.13 -$0.04
08/06/2024 Q2 $10M $7.3M -$0.13 -$0.14 $0.01
05/07/2024 Q1 $11M $10M -$0.14 -$0.16 $0.02
02/20/2024 Q4 $9.3M $9.2M -$0.17 -$0.12 -$0.05
11/02/2023 Q3 -- -- -$0.10 -$0.13 $0.03
08/03/2023 Q2 -- -- -$0.11 -$0.12 $0.01
05/04/2023 Q1 -- -- -$0.14 -$0.13 -$0.01
02/21/2023 Q4 -- -- -$0.10 -$0.01 -$0.09
11/08/2022 Q3 -- -- $0.08 $0.05 $0.04
08/09/2022 Q2 -- -- -$0.02 -$0.00 -$0.02
05/10/2022 Q1 -- -- $0.54 $0.42 $0.12
02/24/2022 Q4 -- -- $0.19 $0.18 $0.02
11/09/2021 Q3 -- -- -$0.08 -$0.06 -$0.02
08/12/2021 Q2 -- -- -$0.01 $0.09 -$0.10
05/13/2021 Q1 -- -- $0.37 -- --
03/29/2021 Q4 -- -- $0.31 -- --
09/30/2020 Q3 -- -- -$0.01 -- --
06/30/2020 Q2 -- -- $0.03 -- --
03/31/2020 Q1 -- -- -$0.01 -- --
12/31/2019 Q4 -- -- -$0.01 -- --

AbCellera Biologics, Inc. Earnings Questions

  • How Much did AbCellera Biologics, Inc. Generate in Revenue Last Quarter?

    AbCellera Biologics, Inc. reported $9M worth of top line sales in its most recent quarter.

  • Did AbCellera Biologics, Inc. Beat Earnings Last Quarter?

    AbCellera Biologics, Inc. announced earnings per share of -$0.19 which represents a miss of analyst forecast a -$0.16 per share.

  • Is AbCellera Biologics, Inc. Profitable?

    AbCellera Biologics, Inc. reported $1.7M that represents $0.01 per share over the last quarter.

  • What is the Analyst Consensus for AbCellera Biologics, Inc. EPS Next Year?

    AbCellera Biologics, Inc.'s earnings are forecast to decrease from -$0.55 per share to -$0.65 per share next year representing a decrease of -17.93%.

  • When is AbCellera Biologics, Inc.'s Earnings Date?

    AbCellera Biologics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock